Steinmaurer Martina, Sandmeyer Jakob, Sinner Moritz F, Lu Kun, Hagl Christian
Klinikum der Universität München, Standort Großhadern, Marchioninistraße 15, 81377 Munich, Germany.
Eur Heart J Case Rep. 2024 Aug 16;8(8):ytae372. doi: 10.1093/ehjcr/ytae372. eCollection 2024 Aug.
Arrhythmic mitral valve prolapse syndrome (ARMV) is a recognized but underdiagnosed disease pattern. Risk factors for ARMV are established but not very well known, and the association of the structural abnormality with ventricular arrhythmias is incompletely understood.
Here, we present the case of a young man who presented at our hospital for radiofrequency catheter ablation and mitral valve surgery after two episodes of survived sudden cardiac arrest. We discuss the diagnostic and therapeutic strategies that were used. We shine light on the risk factors for ARMV and why early identification is crucial. We address the topic of primary prevention and its limitations. Finally, we discuss different treatment modalities for patients with ARMV.
More awareness for ARMV is crucial. A consensus statement on clinical management exists, but scientific gaps in prospective data for primary prevention need to be filled and there is a need for a better understanding of the pathogenesis of ARMV.
心律失常性二尖瓣脱垂综合征(ARMV)是一种已被认可但诊断不足的疾病模式。ARMV的危险因素已明确,但尚未广为人知,且结构异常与室性心律失常之间的关联尚未完全明了。
在此,我们报告一例年轻男性患者,其在经历两次心脏骤停存活后到我院接受射频导管消融术和二尖瓣手术。我们讨论了所采用的诊断和治疗策略。我们阐明了ARMV的危险因素以及早期识别为何至关重要。我们探讨了一级预防的话题及其局限性。最后,我们讨论了ARMV患者的不同治疗方式。
提高对ARMV的认识至关重要。关于临床管理存在一份共识声明,但一级预防前瞻性数据中的科学空白有待填补,且需要更好地理解ARMV的发病机制。